Preferred Label : HLA-B44-Restricted MAGE-3 Peptide;
NCIt definition : A peptide comprised of the synthetic human leukocyte antigen (HLA)-B44-binding peptides
derived from amino acid sequences of MAGE-3 with potential antitumor activity. Vaccination
with HLA-B44-restricted MAGE-3 peptide may elicit a cytotoxic T lymphocyte immune
response against tumor cells expressing MAGE-3. MAGE-3 is an antigen found on many
tumor cell types, including melanoma and lung, prostate, colon, thyroid, and breast
cancers.;
NSC code : 731577;
Origin ID : C48633;
UMLS CUI : C1708277;
Semantic type(s)
concept_is_in_subset